Skip to main content
logo
BioPharma Credit PLC (LON:BPCR)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.9760
+0.0060 (0.62%)
Oct 15, 2026, 2:12 PM GMT

BioPharma Credit Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
107.49129.89122.18108.45182.3184.96
Loss (Gain) From Sale of Investments
-16.75-17.520.0923.95-5.9523.75
Other Operating Activities
-0.01-0.0400.010.030.02
Change in Accounts Receivable
39.47-21.8-11.48-0.48-9.83-9.8
Change in Accounts Payable
-4.260.561.12-8.7417.71-2.49
Operating Cash Flow
125.9491.1111.91123.18184.2896.44
Operating Cash Flow Growth
28.48%-18.60%-9.15%-33.15%91.09%66.06%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
57.4577.4839.07-1.6648.19-94.82
Investing Cash Flow
57.4577.4839.07-1.6648.19-94.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Repurchase of Common Stock
-6.75-51.27-105.75-17.22-50.09-
Common Dividends Paid
-78.97-79.96-109.02-68.95-95.74-96.17
Financing Cash Flow
-119-161.65-280.42-106.99-206.62-100.16

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.010.04-0-0.01-0.03-0.02
Net Cash Flow
64.416.97-129.4314.5325.82-98.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
100.8859.0366.956.88124.0940.26
Unlevered Free Cash Flow
100.8859.0366.956.88124.0940.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
35.21-21.24-10.36-9.227.88-12.29